PAGE 1 | 2 | 3 | 4 | 5 | 6
In 1972, the Sloan Memmorial Ketering Cancer Reasearch (SMKR) commissioned their top senior cancer researcher to conduct tests over a 5 year period between 1972 and 1977 and finally put an end to this laetrile quackery. They asked Dr. Kanematsu Sugiura, their most senior researcher with over 60 years experience in cancer research, who had been under their employment since 1917 and was totally dedicated to cancer research.
Dr. Kanematsu Sugiura's work was trusted, and his honesty and integrity was admired and unquestioned by all. Hundreds of Segiura's research papers were published. Dr Chester Stock, the Head of Sloan Kettering's laboratory-testing division even wrote:
"Few if any names in cancer research are as widely known as Kanematsu Segiura's....Possibly the highest regard in which his work is held is best characterised by a comment made to me by a visiting investigator in cancer research from Russia. He said 'when Segiura publishes, we know we do not have to repeat the study, for we would obtain the same results he has reported'."
At the conclusion of the trials, on June 15, 1977, the SMKCR released a press statement. On the Dais were physicians with impeccable credentials. Dr. Robert Good began to speak. After general remarks condemning laetrile and its use, he passed the microphone to Dr. Stock.
The same Doctor Chester Stock who had praised Segiura's work reversed his views and did not support the research at all. Could politics again be playing a part in the progress of science? The press release said, "...laetrile was found to possess neither preventative, nor tumor-regressent, nor anti-metastatic, nor curative anticancer activity." Buit, then a journalist, stood up and asked "Dr. Kenamatsu Sugiura do you stick by your belief that laetrile stops the spread of cancer?” He replied; " I stick. "
Those two words must have been like knives to the accumulated demi-gods on the dais. The reason being is that Dr. Kanematsu Sugiura was the pre-eminent cancer researcher in America, probably the world, at this time. Dr. Sugiura had been researching cancer since 1911.
Dr. Sugiura said, "The most interesting part is metastases. Secondary cancer growth to another location. When this mammary tumor grows to about two centimetres in diameter or more, about 80% develop lung metastases. But with treatment with laetrile/amygdalin, it's cut down to about 20%. "
PAGE 1 | 2 | 3 | 4 | 5 | 6